Stock TOI THE ONCOLOGY INSTITUTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News The Oncology Institute, Inc.

Equities

TOI

US68236X1000

End-of-day quote Nasdaq
Other stock markets
 23:00:00 12/05/2024 BST 		5-day change 1st Jan Change
0.8692 USD -6.54% Intraday chart for The Oncology Institute, Inc. -7.60% -57.39%
04-08 The Oncology Institute, Inc. Appoints Jordan McInerney as New Chief Development Officer CI
04-04 The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
GL
The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
AQ
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
GL
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
AQ
Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
GL
The Oncology Institute, Inc. Appoints Jordan McInerney as New Chief Development Officer
CI
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
GL
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
CI
Transcript : The Oncology Institute, Inc., Q4 2023 Earnings Call, Mar 27, 2024
The Oncology Institute Q4 Loss Widens, Revenue Increases
MT
(TOI) THE ONCOLOGY INSTITUTE Forecasts Fiscal Year 2024 Revenue Range $400M - $415M
MT
Earnings Flash (TOI) THE ONCOLOGY INSTITUTE Posts Q4 Revenue $85.8M
MT
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
GL
The Oncology Institute, Inc. Provides Earnings Guidance for the Year 2024
CI
The Oncology Institute, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
GL
MaxHealth & The Oncology Institute, Inc. Expand Value-Based Care Partnership
CI
The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
GL
The Oncology Institute to Participate at Upcoming Investor Conferences
GL
Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TOI Stock
  4. News The Oncology Institute, Inc.